Keywords: new, clinical, data, back, up, raptiva, efficacy

New clinical data back up Raptiva's efficacy in psoriasis; other AAD news

Article | 31 March 2003

Print This

Raptiva (efalizumab), developed by Xoma and Genentech in the USA andlicensed to Serono in Europe, has shown efficacy in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in